FIELD: chemistry.
SUBSTANCE: invention relates to novel 2-(chromeno[4,3-d]pyrimidin-5-yl)acetic acid derivative of general formula I and a method for production thereof. In general formula I (a-aa)
R1=Cl, R2=H, R3=H, R4=CH3, EWG=COOC2H5 (Ia); or R1=H, R2=H, R3=H, R4=CH3, EWG=COOC2H5 (Ib); or R1=CH3, R2=H, R3=H, R4=CH3, EWG=COOC2H5 (Ic); or R1=Br, R2=H, R3=H, R4=CH3, EWG=COOC2H5 (Id); or R1=F, R2=H, R3=H, R4=CH3, EWG=COOC2H5 (Ie); or R1=NO2, R2=H5 R3=H, R4=CH3, EWG=COOC2H5 (If); or R1=CH3O R2=H, R3=H, R4=CH3, EWG=COOC2H5 (Ig); or R1=OH, R2=H, R3=H, R4=CH3, EWG=COOC2H5 (Ih); or R1=H, R2=CH3, R3=H, R4=CH3, EWG=COOC2H5 (Ii); or R1=H, R2=OH, R3=H, R4=CH3, EWG=COOC2H5 (Ij); or R1=CH3, R2=CH3, R3=H, R4=CH3, EWG=COOC2H5 (Ik); R1=F, R2=F, R3=H, R4=CH3, EWG=COOC2H5 (Il); R1=CH3, R2=H, R3=Br, R4=CH3, EWG=COOC2H5 (Im); R1=CH3, R2=H, R3=NO2, R4=CH3, EWG=COOC2H5 (In); or R1=Br, R2=CH3O, R3=H, R4=CH3, EWG=COOC2H5 (Io); or R1=Cl, R2=H, R3=H, R4=H, EWG=COOC2H5 (Ip); R1=Cl, R2=H, R3=H, R4=Ph, EWG=COOC2H5 (Iq); or R1=Cl, R2=H, R3=H, R4=4-CH3Ph, EWG=COOC2H5 (Ir); or R1=Cl, R2=H, R3=H, R4=NH2, EWG=COOC2H5 (Is); or R1=Cl, R2=H, R3=H, R4=CH3O, EWG=COOC2H5 (It); or R1=Cl, R2=H, R3=H, R4=CH3S, EWG=COOC2H5 (Iu); or R1=Cl, R2=H, R3=H, R4=BnS, EWG=COOC2H5 (Iv); or R1=Cl, R2=H, R3=H, R4=CH3, EWG=COOH (Iw); or R1=Cl, R2=H, R3=H, R4=CH3, EWG=CONH2 (Ix); or R1=Cl, R2=H, R3=H, R4=CH3, EWG=CON(C2H5)2 (Iy); or R1=Cl, R2=H, R3=H, R4=CH3, EWG=COC4H8N2CH3 (Iz); or R1=Cl, R2=H, R3=H, R4=CH3, EWG=CN (Iaa). Method of producing a compound of general formula I is carried out by reacting 3-substituted chromone with a binucleophilic reagent, wherein 3-substituted chromone used is electron-deficient 3-vinylchromone selected from the group: ethyl-3-(6-chloro-4-oxo-4H-chromen-3-yl)acrylate, ethyl-3-(4-oxo-4H-chromen-3-yl)acrylate, ethyl-3-(6-methyl -4-oxo-4H-chromen-3-yl)acrylate, ethyl-3-(6-bromo-4-oxo-4H-chromen-3-yl)acrylate, ethyl-3-(6-fluoro-4-oxo-4H-chromen-3-yl)acrylate, ethyl-3-(6-nitro-4-oxo-4H-chromene-3-yl)acrylate, ethyl-3-(6-methoxy-4-oxo-4H-chromen-3-yl)acrylate, ethyl-3-(6-hydroxy-4-oxo-4H-chromene-3-yl)acrylate, ethyl-3-(7-methyl-4-oxo-4H-chromen-3-yl)acrylate, ethyl-3-(7-hydroxy -4-oxo-4H-chromen-3-yl)acrylate, ethyl-3-(6,7-dimethyl-4-oxo-4H-chromene-3-yl)acrylate, ethyl-3-(6,7-difluoro-4-oxo-4H-chromen-3-yl)acrylate, ethyl-3-(8-bromo-6-methyl-4-oxo-4H-chromen-3-yl)acrylate, ethyl-3-(6-methyl-8-nitro-4-oxo-4H-chromen-3-yl)acrylate, ethyl-3-(6-bromo-6-methoxy-4-oxo-4H-chromene-3-yl)acrylate, ethyl-3-(6-chloro-4-oxo-4H-chromene-3-yl)acrylate, 3-(6-chloro-4-oxo-4H-chromen-3-yl)acrylic acid, 3-(6-chloro-4-oxo-4H-chromen-3-yl)acrylamide, N,N-diethyl-3-(6-chloro-4-oxo-4H-chromen-3-yl)acrylamide, 3-(6-chloro-4-oxo-4H-chromen-3-yl)-1-(4-methylpiperazin-1-yl)prop-2-en-1-one, 3-(6-chloro-4-oxo- 4H-chromen-3-yl)acrylonitrile, and corresponding 1,3-N,N-binucleophilic reagent is selected from amidine, guanidine or isourea derivative, which is generated directly in reaction mass from its salt – chloride or sulphate, under action of strong base – sodium ethylate, sodium hydroxide, 1,8-diazabicyclo[5.4.0]undec-7-ene. Process is carried out in ethanol at temperature of 15–25 °C, and the end product is extracted in the form of a precipitate by pouring the reaction mixture into 1M hydrochloric acid or water.
EFFECT: compound has fluorescence in the violet-blue spectrum of 390–455 nm and can be used as fluorescent dyes and / or probes in biochemical studies.
2 cl, 1 tbl, 27 ex
Title | Year | Author | Number |
---|---|---|---|
ETHYL-2-(9-AMINOCHROMENO[4,3-D]PYRIMIDINE-5-YL)ACETATES AND THEIR PREPARATION METHOD | 2020 |
|
RU2746879C1 |
2-(CHROMENO[4,3-B]PYRIDIN-5-YL)ACETIC ACID DERIVATIVES AND METHOD FOR THEIR PREPARATION | 2021 |
|
RU2793186C1 |
DERIVATIVES OF 2-(PYRANO[3,2-C]CHROMEN-5-YL)ACETIC ACID AND METHOD FOR THEIR PREPARATION | 2021 |
|
RU2775546C1 |
METHOD OF PRODUCING 4-ARYL-2-OXO-2H-CHROMENE-3-CARBONITRILES | 2015 |
|
RU2577524C1 |
METHOD FOR PRODUCING SUBSTITUTED (4R*,5S*,6R*)-2-THIOHEXAHYDROPYRIMIDINE-5-CARBOHYDRAZIDES | 2021 |
|
RU2776954C1 |
METHOD FOR PREPARING SUBSTITUTED O-ALKYLATED HEXAHYDRO-2H-CHROMENO[4,3-D]PYRIMIDINE-2,5(1H)-DIONES | 2022 |
|
RU2796532C1 |
NOVEL COUMARIN DERIVATIVES WITH ANTI-TUMOUR ACTIVITY | 2007 |
|
RU2428420C2 |
NITROGEN-CONTAINING AROMATIC DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR TREATMENT AND USING | 2003 |
|
RU2310651C2 |
BICYCLIC HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS | 2020 |
|
RU2811612C2 |
PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF | 2014 |
|
RU2663898C2 |
Authors
Dates
2020-03-13—Published
2019-11-29—Filed